InvestorsHub Logo

Squeejo

12/02/15 4:49 PM

#14066 RE: TheTradingNinja #14062

Current Report Filing (8-k)

Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): September 22, 2015

Be Active Holdings, Inc.
(Exact name of registrant as specified in its charter)

Delaware

000-55185

68-0678429
(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

1010 Northern Blvd., Great Neck, NY

11021
(Address of principal executive offices)

(Zip Code)

(212) 736-2310
(Registrant’s telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

| | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

| | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

| | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Section 1 – Registrant’s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.

On September 22, 2015, Be Active Holdings, Inc. (the “Company”) closed on a $250,000 financing in accordance with the terms of a Consent, Waiver and Modification Agreement. Pursuant to said agreement, the Company issued five allonges to the previous secured convertible promissory notes issued by the Company in December 2014 (see the Current Report on Form 8-K dated December 31, 2014 and filed with the Securities and Exchange Commission on January 7, 2014). The maturity date of the allonges is September 30, 2016 and the conversion rate of the notes was decreased to $.001.

In connection with the financing, the Company agreed to increase the conversion rate of the outstanding Series C Preferred Stock from one share to five shares of common stock and to effectuate a reverse stock split prior to November 20, 2015. If the appropriate filings are not made by such time to take such actions, Alpha Capital Anstalt has the right to declare such failure an event of default pursuant to its secured convertible promissory note and to also require the Company to purchase its Series C Preferred Stock.

Palladium Capital Advisors LLC was issued an allonge in the amount of $25,000 as placement agent for the financing.

For all the terms and conditions of the Consent, Waiver and Modification Agreement and the allonges described above, reference is hereby made to such Agreement and Note annexed hereto as Exhibit 10.13 and Exhibit 10.14, respectively. All statements made herein concerning the foregoing Agreement and allonges are qualified by reference to said Exhibits.

Section 2 - Financial Information
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth above under Item 1.01 (Entry into a Material Definitive Agreement) above is incorporated by reference into this Item 2.03.

Section 3 - Securities and Trading Markets
Item 3.02 Unregistered Sales of Equity Securities.

The disclosure set forth above under Item 1.01 (Entry into a Material Definitive Agreement) above is incorporated by reference into this Item 3.02. The allonges described in Item 1.01 above was issued in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The allonges executed in connection therewith contains representations to support the Company's reasonable belief that each of the investors had access to information concerning the operations and financial condition of the Company, is acquiring the securities for its own account and not with a view to the distribution thereof, and is an "accredited investor" as such term is defined in Rule 501 (a) of Regulation D promulgated under the Securities Act. At the time of their issuance, the allonges and any shares of common stock issued upon conversion thereof above will be deemed to be restricted securities for purposes of the Securities Act and the certificates representing the securities shall bear legends to that effect.

Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

10.13
Consent, Waiver and Modification Agreement, dated September 21, 2015, between the Company and each of the signatories thereto.

10.14
Allonge No. 1 to Secured Note issued December 31, 2015.






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



BE ACTIVE HOLDINGS, INC.


Dated: September 24, 2015
By:
/s/ Joseph Rienzi

Name:
Joseph Rienzi

Title:
Interim President





Exhibit 10.13

CONSENT, WAIVER AND MODIFICATION AGREEMENT

This Consent, Waiver and Modification Agreement (“Agreement”) is made and entered into as of September 21, 2015, by and among Be Active Holdings Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in each of the February 2014 Securities Purchase Agreements, December 2014 Securities Purchase Agreements, February 2014 Transaction Documents and December 2014 Transaction Documents (all as defined below).

WHEREAS, the Company and Purchasers identified on Schedule A entered into Securities Purchase Agreements (the “February 2014 Securities Purchase Agreements”) and related Transaction Documents with respect to the Securities identified on Schedule A (“February 2014 Transaction Documents”) as of February 18, 2014; and

WHEREAS, pursuant to the terms of the February 2014 Securities Purchase Agreements, the Company issued to the Purchasers Common Stock, Series C Preferred Stock (“Preferred Stock”) and Warrants (the “Warrants”); and

WHEREAS, the Company and Purchasers identified on Schedule B entered into Securities Purchase Agreements (the “December 2014 Securities Purchase Agreements”) and related Transaction Documents with respect to the Securities identified on Schedule B (“December 2014 Transaction Documents”) as of December 31, 2014; and

WHEREAS, pursuant to the terms of the December 2014 Securities Purchase Agreements, the Company issued to the Purchasers Secured Convertible Notes (“December 2014 Notes”); and

WHEREAS, the Company is contemplating an additional offering of an aggregate $250,000 Purchase Price (“New Offering”) on substantially the same terms and conditions as the December 2014 Notes, as modified herein; and

WHEREAS, in connection with the New Offering, the Company intends to issue allonges to the December 2014 Notes increasing the principal amount of the Notes (“Allonges”) pursuant to the terms of the New Offering with such Allonges having a Maturity Date of September 30, 2016 and a Conversion Price equal to $0.001 per Share (subject to further reduction); and

WHEREAS, in connection with the New Offering, the Company has agreed to issue to the Placement Agent, Palladium Capital Advisors LLC, a fee equal to $25,000 in the form of a Secured Convertible Promissory Note identical to the form of the December 2014 Note and Allonge issued and to be issued to the Purchasers in the New Offering; and

WHEREAS, in connection with the New Offering, each Purchaser possesses a right of participation (“Right of Participation”) and certain rights (“MFN Rights”) pursuant to Sections 4.12 and 4.15 respectively of each of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements; and

WHEREAS, pursuant to Section 4.14 of the December 2014 Securities Purchase Agreements, upon a Share Dilutive Issuance, the Purchasers are entitled to a Share Dilution Adjustment; and

WHEREAS, pursuant to Section 4.20 of each of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements, the Company is prohibited, without the prior approval of Purchasers, from entering into any Variable Rate Transactions nor issuing any Variable Price Linked Equity Securities and certain other restrictions described in the last sentence of Section 4.20; and


1


WHEREAS, solely in connection with the New Offering, Purchasers will (i) waive the Right of Participation, (ii) waive their MFN Rights, (iii) release the Company from the restrictions described in the tenth recital above, and (iv) consent to the issuance of the Allonges by the Company in connection with the New Offering; and

WHEREAS, pursuant to Section 5.5 of each of the February 2014 Securities Purchase Agreement and December 2014 Securities Purchase Agreement, a Majority in Interest may consent to a modification of any provision of the respective Securities Purchase Agreements on behalf of the Purchasers.

NOW THEREFORE, in consideration of promises and mutual covenants contained herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby consent and agree as follows:

1. Upon the execution of this Agreement by a Majority in Interest, the Purchasers waive (i) the Right of Participation and their MFN Rights; and (ii) release the Company from the restrictions described in the tenth recital above.

2. Pursuant to Section 4.14 of the December 2014 Securities Purchase Agreement from and after the closing of the New Offering, the Company hereby agrees and acknowledges that, effective immediately, the Conversion Price of the December 2014 Notes issued to the Purchasers pursuant to the December 2014 Securities Purchase Agreements is $0.001, subject to further reduction as described in the December 2014 Transaction Documents.

3. The Company acknowledges that prior to the closing date of the New Offering, the Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock will have been amended so that upon conversion of each Series C Preferred Share, five (5) shares of Common Stock will be issued. A copy of the filed amendment will be delivered to all holders of Series C Preferred Shares on or before the closing of the New Offering.

4. On or before fifty (50) days following the closing of the New Offering, the Company undertakes to effectuate a reverse split in the ratio of a range of one new Share of Common Stock for each outstanding two Shares of Common Stock up to one new share of Common Stock for each outstanding one thousand Shares of Common Stock, and to reserve on behalf of the Purchasers within one business day after the effectuation of the reverse split the amount of Common Stock necessary for the Company to comply with all reservation obligations owed to Purchasers. Shares issuable upon conversion of the principal represented by the Allonge and interest thereon are included in the definition of “Required Minimum” as defined in the December 2014 Transaction Documents. Failure to timely effectuate the reverse split or reserve such shares is an Event of Default under the December 2014 Notes. The company will not increase the par value of the Common Stock in connection with the reverse split.

5. Each of the Purchasers hereby represents the truth and accuracy of each Purchaser’s representations and warranties contained in the December 2014 Transaction Documents when made and also as if such representations and warranties were made as of the date hereof, except with respect to Section 3.2(j) of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements in connection with which trading might have been done in reliance on Section 4.2(i) of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements. The Company hereby represents the truth and accuracy of all of the Company’s representations and warranties contained in the December 2014 Transaction Documents when made and also as if such representations and warranties were made as of the date hereof, except as same have been modified or updated in Schedule C or in the SEC Reports.


2


6. Annexed hereto as Schedule C are the following schedules corresponding to the schedules designations in the December 2014 Securities Purchase Agreements. Schedules which have not changed from those delivered in connection with the December 2014 Securities Purchase Agreements are marked “NO CHANGE”. Schedules which have been updated are provided as of the date of this Agreement and the closing date of the New Offering unless otherwise indicated thereon.

· Schedule 1.1. Exempt Issuances

· Schedule 3.1(a). Subsidiaries

· Schedule 3.1(e) Filings, Consents and Approvals

· Schedule 3.1(g). Capital Structure

· Schedule 3.1(h) Form 8-K; Financial Statements

· Schedule 3.1(i): Material Changes; Undisclosed Events, Liabilities or Developments

· Schedule 3.1(j): Litigation

· Schedule 3.1(n): Title to Assets

· Schedule 3.1(o). Intellectual Property

· Schedule 3.1(s): Certain Fees:

· Schedule 3.1(v). Registration Right

· Schedule 3.1(aa). Solvency

· Schedule 3.1(ee). Accountants

· Schedule 3.1(jj). Stock Option Plans

· Schedule 3.1(ll). Reporting Company/Shell Company

· Schedule 3.1(oo). Related Party Transactions

· Schedule 4.6. Use of Proceeds

7. The Purchasers’ right to participate in a Subsequent Financing as set forth in Section 4.12 of the December 2014 Securities Purchase Agreements is hereby extended until September 30, 2017.

8. The Protection Period as employed in each of the February 2014 Securities Purchase Agreement and the December 2014 Securities Purchase Agreements is hereby extended until September 30, 2018.

9. The restriction described in the last sentence of Section 4.20 in each of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements is extended until September 30, 2016.

10. The principal amount represented by the Allonges will accrue interest at an annual rate of 10% until the reservation described in Section 4 above has been effectuated and the Required Minimum has been reserved and will be payable and subject to the terms and conditions applicable to interest under the December 2014 Notes.


3


11. Shares issuable upon the conversion of the principal amount of Allonges and interest therein are included in the definition of “Securities” as defined in the December 2014 Transaction Documents.

12. The Company hereby permanently waives the redemption and mandatory conversion provisions contained in Section 6 of the December 2014 Notes.

13. This Agreement and the New Offering Escrow Agreement shall be included in the definition of each of the February 2014 Transaction Documents and December 2014 Transaction Documents.

14. The undersigned consent to the Company completing the New Offering and to the amendment of the Security Agreement and Guaranty to include the New Offering as a component of the Obligations to be secured by the Collateral pursuant to the Security Agreement entered into in connection with the December 2014 Transaction Documents. In connection therewith, the Company and Purchasers authorize the Collateral Agent to make such additional filings at the discretion of the Collateral Agent to memorialize such agreement.

15. Annexed hereto is Amended Schedule A to the Security Agreement and the Guaranty.

16. If the closing of the New Offering has not occurred by September 30, 2015, this Agreement will be null and void.

17. Each of the Purchasers executing this Agreement represents to the Company that it has the authority to enter into and deliver this Agreement.

18. The Company represents to the Purchasers that the books and records of the Company accurately reflect the information described on Schedules A and B.

19. Except as specifically described herein, there is no other waiver expressed or implied.

20. In this Agreement words importing the singular number include the plural and vice versa; words importing the masculine gender include the feminine and neutral genders. The word “person” includes an individual, body corporate, partnership, trustee or trust or unincorporated association executor, administrator or legal representative.

21. This Agreement will be subject to amendment and/or waiver in the same manner and subject to the same requirements as described in the February 2014 Transaction Documents and December 2014 Transaction Documents.

22. The closing of the New Offering will be subject to the procedures set forth in a New Offering Escrow Agreement to be entered into by the Company, each of the Purchasers and the Escrow Agent identified therein.

23. The invalidity or unenforceability of any provision hereof will in no way affect the validity or enforceability of any other provision.

24. All notices, demands, requests, consents, approvals, and other communications required or permitted in connection with this Agreement shall be made and given in the same manner set forth in Section 5.4 of each of the February 2014 Securities Purchase Agreements and December 2014 Securities Purchase Agreements.

25. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflicts of laws and principles that would result in the application of the substantive laws of another jurisdiction. Any action brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of New York in the federal courts located in the state of New York. Both parties and the individuals executing this Agreement and other agreements on behalf of the parties agree to submit to the jurisdiction of such courts and waive trial by jury. The prevailing party (which shall be the party which receives an award most closely resembling the remedy or action sought) shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.


4


26. The division of this Agreement into articles, sections, subsections and paragraphs and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this agreement.

27. This Agreement may be executed in counterparts, all of which when taken together shall be considered one and the same Agreement and shall become effective when the counterparts have been signed by each party and delivered to the other party, it is being understood that all parties need not sign the same counterpart. In the event that any signature is delivered by facsimile or PDF transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature were an original thereof.


(Signatures to follow)


5


IN WITNESS WHEREOF, the Company, Guarantor, Collateral Agent and the undersigned Purchasers have caused this Agreement to be executed as of the date first written above.


BE ACTIVE HOLDINGS INC.
the “Company”


By /s/ Sam Pugliese



BE ACTIVE BRANDS INC.
the “Guarantor”


By: /s/ Sam Pugliese


COLLATERAL AGENT


/s/ John S. Lemak
JOHN S. LEMAK




[Purchasers’ Signature Pages to Follow]


6



PURCHASERS’ SIGNATURE PAGE TO CONSENT WAIVER & MODIFICATION AGREEMENT

“PURCHASER”


HS CONTRARIAN INVESTMENTS LLC

By: /s/ John Stetson
Name: John Stetson
Title: Managing Member


MICHAEL BRAUSER

________________________________________




ALPHA CAPITAL ANSTALT

By: /s/ Konrad Ackermann
Name: Konrad Ackermann
Title: Director


THE JOHN ST. THOMAS AND BARBARA ST.
THOMAS REV. 2005 TRUST DTD 9/9/2005 JOHN
ST. THOMAS & BARBARA ST. THOMAS TTEES

By: /s/ John Stetson
Name: John Stetson
Title: Trustee


STRATCON PARTNERS

By: ____________________________________
Name:
TItle:


SANDOR CAPITAL MASTER FUND

By: /s/ John S. Lemak
Name: John S. Lemak
Title: Manager

GRQ CONSULTATS INC. 401K

By: /s/ Barry Honig
Name: Barry Honig
Title: Trustee


BIRCHTREE CAPITAL LLC

By: ___________________________________
Name:
Title


MOMONA CAPITAL

By: ___________________________________
Name:
Title




BRIO CAPITAL MASTER FUND LTD.

By: /s/ Shaye Hirsch
Name: Shaye Hirsch
Title: Director


BST COLD LLC

By: ____________________________________
Name:
Title:


POINT CAPITAL INC.

By: ____________________________________
Name:
Title:


7



PURCHASERS’ SIGNATURE PAGE TO CONSENT WAIVER & MODIFICATION AGREEMENT

“PURCHASER”

JILL STRAUSS

________________________________________


DENVILLE AND DOVER FUND LLC

By: ____________________________________
Name:
Title:


JSL KIDS PARTNERS

By: /s/ John S. Lemak
Name: John S. Lemak
Title: Manager

CRAIG GOODSTADT

________________________________________


MELECHDAVID INC. RETIREMENT PLAN

By: ___________________________________
Name:
Title


BARRY HONIG

/s/ Barry Honig



8



SCHEDULE A CONSENT WAIVER AND MODIFICATION AGREEMENT

FEBRUARY 2014 PURCHASERS

PURCHASERS
SUBSCRIPTION AMOUNT
HS CONTRARIAN INVESTMENTS LLC
347 N. New River Drive East, #804
Fort Lauderdale, FL 33301
$150,000.00
GRQ CONSULTANTS INC. 401K
555 S. Federal Highway, #450
Boca Raton, FL 33432
Fax: 561-235-5379
$150,000.00
MICHAEL BRAUSER
4400 Biscayne Blvd., #850
Miami, FL 33137
Fax: 305-576-9298
$150,000.00
BIRCHTREE CAPITAL LLC
4400 Biscayne Blvd., #850
Miami, FL 33137
Fax: 305-576-9298
$100,000.00
ALPHA CAPITAL ANSTALT
Pradafant 7
9490 Furstentums
Vaduz, Lichtenstein
Fax: 212-586-8244
$500,000.00
MOMONA CAPITAL
510 Madison Avenue
New York, NY 10022
Fax: 212-586-8244
$50,000.00
THE JOHN ST. THOMAS AND BARBARA ST. THOMAS REV. 2005 TRUST DTD 9/9/2005
JOHN ST. THOMAS & BARBARA ST. THOMAS TTEES
10315 Cresta Drive
Los Angeles, CA 90064
Tel.: 310-858-4825
$20,000.00
BRIO CAPITAL MASTER FUND LTD.
100 Merrick Road, Suite 401W
Rockville Center, NY 11570
Tel.: 516-536-0500
$200,000.00
STRATCON PARTNERS
155 West 68th Street, #27E
New York, NY 10023
Tel.: 658-7878
$25,000.00
BST COLD LLC
1601 Sunset Plaza Drive
Los Angeles, CA 90069
Fax: 310-855-9475
$50,000.00
SANDOR CAPITAL MASTER FUND
2828 Routh Street, Suite 500
Dallas, TX 75201
Tel.: 214-849-9876

$99,999.99
POINT CAPITAL INC.
285 Grand Avenue
Building 5, 2nd Floor
Englewood, NJ 07631
Tel.: 201-408-5126
$100,000.00
JILL STRAUSS
224 Quadro Vecchio Drive
Pacific Palisades, CA 90272
Fax: 310-855-9475
$25,000.00
CRAIG GOODSTADT
112 Chopin Drive
Wayne, NJ 07470
Tel.: 201-390-0994
$15,000.00
DENVILLE AND DOVER FUND LLC
4 South Orange Avenue, Unit 170
South Orange, NJ 07079
$115,000.00
MELECHDAVID, INC. RETIREMENT PLAN
100 S. Pointe Drive, #1405
Miami Beach, FL 33130
Fax: 860-476-1582
$50,000.00
TOTAL
$1,799,999.99


* All share numbers disclosed herein are reflected as “pre-split” numbers.


9



SCHEDULE B CONSENT WAIVER AND MODIFICATION AGREEMENT

DECEMBER 2014 PURCHASERS


PURCHASERS
SUBSCRIPTION AMOUNT
ALPHA CAPITAL ANSTALT
Lettstrasse 32
P.O. Box 1212
9490 Vaduz, Lichtenstein
Fax: 212-586-8244
Taxpayer ID# None
$75,000.00
BRIO CAPITAL MASTER FUND LTD.
100 Merrick Road, Suite 401W
Rockville Center, NY 11570
Tel.: 516-536-0500
Taxpayer ID# 98-1072321
$50,000.00
SANDOR CAPITAL MASTER FUND
2828 Routh Street, Suite 500
Dallas, TX 75201
Tel.: 214-849-9876
Taxpayer ID#: 27-0013809
$165,000.00
JSL KIDS PARTNERS
2828 Routh Street, Suite 500
Dallas, TX 75201
Tel.: 214-849-9876
Taxpayer ID#: 38-3784405
$35,000.00
BARRY HONIG
555 S. Federal Highway, Suite 450
Boca Raton, FL 33432
Taxpayer ID#: 118-66-6789
$100,000.00
TOTAL
$425,000.00


* All share numbers disclosed herein are reflected as “pre-split” numbers.




Exhibit 10.14

ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to Sandor Capital Master Fund (“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $90,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ David J. Woflson
David J. Wolfson
CFO






ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to Alpha Capital Anstalt (“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $85,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ David J. Wolfson
David J. Wolfson
CFO





ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to Barry Honig (“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $30,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ David J. Wolfson
David J. Wolfson
CFO





ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to Brio Capital Master Fund(“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $35,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ David J. Wolfson
David J. Wolfson
CFO





ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to JSL Kids Partners (“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $10,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ David J. Wolfson
David J. Wolfson
CFO





ALLONGE NO. 1 TO SECURED NOTE ISSUED DECEMBER 31, 2014


This Allonge No. 1 to Secured Note (“Allonge”) is made as of this 21st day of September, 2015, by Be Active Holdings, Inc., a Delaware corporation (“Borrower”) to Palladium Capital Advisors LLC (“Lender”). This Allonge is being issued pursuant to a Consent, Waiver and Modification Agreement dated on or about the date of this Allonge, the terms of which are incorporated herein by this reference. Reference is hereby made to that certain Secured Note issued by Borrower to Lender dated December 31, 2014 (“Note”). Capitalized terms used in this Allonge not otherwise defined herein shall have the meanings ascribed to such terms in the Note. Except as amended hereby, the terms of the Note remain as originally stated.

The principal amount as stated on the face of the Note shall be increased by $25,000 (“Allonge Principal”) over and above any amounts outstanding immediately prior to the date of this Allonge. This increase to the principal amount due and owing on the Note described herein notwithstanding, Lender does not waive interest that may have accrued at a default rate of interest and liquidated damages, if any, that may have accrued on the Note through the date of this Allonge, which default interest and liquidated damages, if any, remain outstanding and payable.

The Maturity Date with respect to all amounts outstanding immediately prior to the effectiveness of this Allonge shall remain unchanged as the Maturity Date set forth in the Note, subject to acceleration as set forth in the Note. The Maturity Date with respect to the Allonge Principal shall be September 30, 2016. Interest on the Allonge Principal will accrue at an annual rate of 10% until the Required Minimum has been reserved as described in Section 4 of the Consent, Waiver and Modification Agreement and will thereafter cease to accrue.

IN WITNESS WHEREOF, this Allonge is executed as of the date written above.

BE ACTIVE HOLDINGS, INC.



By: /s/ Sam Pugliese
Sam Pugliese
President

Squeejo

12/02/15 4:55 PM

#14067 RE: TheTradingNinja #14062

Proxy Statement (definitive) (def 14a)

Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14C INFORMATION

Information Statement Pursuant to Section 14(c)
of the
Securities Exchange Act of 1934

Check the appropriate box:

o Preliminary Information Statement

o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2))

x Definitive Information Statement

Be Active Holdings, Inc.
(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

x No fee required.

o Fee computed on table below per Exchange Act Rules 14c-5(g)

(1) Title of each class of securities to which transaction applies:

(2) Aggregate number of securities to which transaction applies:

(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4) Proposed maximum aggregate value of transaction:

(5) Total fee paid:

o Fee paid previously with preliminary materials.

o Check box if any part of the fee is offset as provided by Exchange Act Rule O-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1) Amount previously paid:

(2) Form, Schedule, or Registration Statement No.:

(3) Filing Party:

(4) Date Filed:





BE ACTIVE HOLDINGS, INC.
1010 Northern Blvd.
Great Neck, New York 11021


October 22, 2015

Dear Stockholders:

The enclosed Information Statement is being furnished to the holders of record of the shares of the common stock (the “Common Stock”) of Be Active Holdings, Inc., a Delaware corporation (the “Company or “Be Active”), as of the close of business on the record date, September 21, 2015 (the “Record Date”). The purpose of the Information Statement is to notify our stockholders that on September 21, 2015, the Company received a joint written consent in lieu of a meeting (the “Joint Written Consent”) from the members of the Board of Directors (the “Board”) and the holders of no less than 51% of the issued and outstanding shares of our Common Stock (the “Majority Stockholders”) regarding the following items:

1.
The granting of discretionary authority to our Board to implement a reverse stock split of our common stock at some time within twelve months of the Record Date, with the exact amount and time of the reverse split to be determined by the Board of Directors (the “Reverse Split”).

2.
The increase in the authorized shares of common stock the Company is authorized to issue from 750,000,000 to 3,000,000,000 (the “Increase in Authorized Common”).

3.
The change in the conversion rate of the Series C Convertible Preferred Stock from one share of common stock to five shares.

4.
The increase in the number of authorized shares of Series D Convertible Preferred Stock from 1,200,000 to 3,000,000 shares.

You are urged to read the Information Statement in its entirety for a description of the action taken by the Majority Stockholders of the Company. The action will become effective on a date that is not earlier than twenty one (21) calendar days after this Information Statement is first mailed to our stockholders.

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

No action is required by you. The enclosed Information Statement is being furnished to you to inform you that the foregoing action has been approved by the Majority Stockholders. Because the Majority Stockholders have voted in favor of the foregoing actions, and has sufficient voting power to approve such actions through its ownership of Common Stock, no other stockholder consents will be solicited in connection with the transactions described in this Information Statement. The Board is not soliciting your proxy in connection with the adoption of the resolution, and proxies are not requested from stockholders.

This Information Statement is being mailed on or about October 23, 2015 to stockholders of record on the Record Date.




Sincerely,

/s/ Joseph Rienzi
Joseph Rienzi
Interim President





BE ACTIVE HOLDINGS, INC.
1010 Northern Blvd.
Great Neck, New York 11021


INFORMATION STATEMENT
PURSUANT TO SECTION 14(C)
OF THE SECURITIES EXCHANGE ACT OF 1934
AND RULE 14C-2 THEREUNDER
_____________________________________

NO VOTE OR OTHER ACTION OF THE COMPANY’S STOCKHOLDERS IS REQUIRED IN CONNECTION WITH THIS INFORMATION STATEMENT.

WE ARE NOT ASKING YOU FOR A PROXY AND
YOU ARE REQUESTED NOT TO SEND US A PROXY

This notice and Information Statement is being furnished to the holders of record of the shares of the common stock (the “Common Stock”) of Be Active Holdings, Inc., a Delaware corporation (the “Company or “Be Active”), as of the close of business on the record date, September 21, 2015 (the “Record Date”). The purpose of the Information Statement is to notify our stockholders that on September 21, 2015, the Company received a joint written consent in lieu of a meeting (the “Joint Written Consent”) from the members of the Board of Directors (the “Board”) and the holders of no less than 51% of the issued and outstanding shares of our Common Stock (the “Majority Stockholders”) regarding the following items:

1.
The granting of discretionary authority to our Board to implement a reverse stock split of our common stock at some time within twelve months of the Record Date, with the exact amount and time of the reverse split to be determined by the Board of Directors (the “Reverse Split”).

2.
The increase in the authorized shares of common stock the Company is authorized to issue from 750,000,000 to 3,000,000,000 (the “Increase in Authorized Common”).

3.
The change in the conversion rate of the Series C Convertible Preferred Stock from one share of common stock to five shares.

4.
The increase in the number of authorized shares of Series D Convertible Preferred Stock from 1,200,000 to 3,000,000 shares.

This notice and Information Statement shall be considered the notice required under Section 228(e) of the Delaware General Corporation Law (the "DGCL"). The action will become effective on a date that is not earlier than twenty one (21) calendar days after this Information Statement is first mailed to our stockholders.

Because the Majority Stockholders have voted in favor of the foregoing action, and has sufficient voting power to approve such actions through his ownership of Common Stock, no other stockholder consents will be solicited in connection with the transactions described in this Information Statement. The Board is not soliciting proxies in connection with the adoption of these resolutions, and proxies are not requested from stockholders.

As of the Record Date, we had 490,595,671 shares of Common Stock issued and outstanding.

Our Board has fixed the close of business on September 21, 2015 as the record date for determining the stockholders entitled to notice of the above noted actions. This Information Statement is being mailed on or about October __, 2015 to stockholders of record on the Record Date.





DISTRIBUTION AND COSTS

We will pay all costs associated with the distribution of this Information Statement, including the costs of printing and mailing. In addition, we will only deliver one Information Statement to multiple security holders sharing an address, unless we have received contrary instructions from one or more of the security holders. Also, we will promptly deliver a separate copy of this Information Statement and future stockholder communication documents to any security holder at a shared address to which a single copy of this Information Statement was delivered, or deliver a single copy of this Information Statement and future stockholder communication documents to any security holder or holders sharing an address to which multiple copies are now delivered, upon written request to us at our address noted above.

Security holders may also address future requests regarding delivery of information statements by contacting us at the address noted above.

VOTE REQUIRED; MANNER OF APPROVAL

Approval to implement the actions authorized by the Joint Consent requires the affirmative vote of the holders of a majority of the voting power of the Company. Because stockholders holding at least a majority of the voting rights of our outstanding shares have voted in favor of the foregoing actions, and have sufficient voting power to approve such actions through their ownership of stock in the Company, no other stockholder consents will be solicited in connection with the transaction described in this Information Statement. The Board is not soliciting proxies in connection with the adoption of these proposals, and proxies are not requested from stockholders.

In addition, the DGCL provides in substance that stockholders may take action without a meeting of the stockholders and without prior notice if a consent or consents in writing, setting forth the action so taken, is signed by the holders of the outstanding voting shares holding not less than the minimum number of votes that would be necessary to approve such action at a stockholders meeting. The action is effective when written consents from holders of record of a majority of the outstanding shares of voting stock are executed and delivered to the Company.

The Company has 490,595,671 shares of Common Stock outstanding, 11,663,921 shares of Series A Convertible Preferred Stock (“Series A”), 20,000,000 shares of Series C Convertible Preferred Stock (“Series C”) and 3,000,000 shares of Series D Convertible Preferred Stock (“Series D”). While the holders of Series A and Series C vote on an as converted basis with the holders of the Common Stock (with each share of Series A and Series C currently entitled to one vote per share of such preferred), the holders of the Series D are entitled to have that number of votes on all matters that is equal to the greater of (i) 100 votes for each one share of Series D and (ii) such number of votes per share of Series D that, when added to the votes per share of all other shares of Series D, shall equal 50.1% of the outstanding voting capital. Accordingly, the votes or written consents of stockholders holding the Series D shares are necessary to implement the actions authorized by the Joint Written Consent.

On September 21, 2015, the Board and the Majority Stockholders executed and delivered to the Company the Joint Written Consent. Accordingly, in compliance with the DGCL, at least a majority of the outstanding shares has approved the Reverse Split, the Increase in Authorized Common, the change in the conversion rate of the Series C and the increase in the authorized amount of Series D. As a result, no vote or proxy is required by the stockholders to approve the adoption of the foregoing actions.

GRANT OF DISCRETIONARY AUTHORITY TO THE BOARD OF DIRECTORS
TO IMPLEMENT A REVERSE STOCK SPLIT

Our Board and the Majority Stockholders have adopted a resolution authorizing, but not requiring, the Board to amend our Certificate of Incorporation to effect a Reverse Split. The reverse split exchange ratio that the directors and stockholders approved and deemed advisable is to be determined in the discretion of the Board. The Board has authority to implement the Reverse Split at any time it determines within twelve months of the Record Date. In addition, this proposal also gives the Board authority to decline to implement a reverse split.

Our Board believes that a range for the exchange ratio of the Reverse Split to be determined (as contrasted with approval of a specified ratio of the split) provides the Board with maximum flexibility to achieve the purposes of a stock split, and, therefore, is in the best interests of our stockholders. The actual ratio for implementation of the reverse split would be determined by our Board based upon its evaluation as to what ratio of pre-consolidation shares to post-consolidation shares would be most advantageous to our stockholders.





Our directors also believe that approval of a twelve-month range for the effectuation of the Reverse Split (as contrasted with approval of a specified time of the split) provides the Board with maximum flexibility to achieve the purposes of a stock split, and, therefore, is in the best interests of our stockholders. The actual timing for implementation of the Reverse Split would be determined by our Board based upon its evaluation as to when and whether such action would be most advantageous to our stockholders.

The Board believes that the higher share price that might initially result from the Reverse Split could help generate interest in the Company among investors and thereby assist us in raising future capital to fund our operations or make acquisitions.

Stockholders should note that the effect of the Reverse Split upon the market price for our Common Stock cannot be accurately predicted. In particular, if we elect to implement the Reverse Split, there is no assurance that prices for shares of our Common Stock will be greater than the price for shares of our Common Stock immediately prior to the Reverse Split, depending on the ratio of the split. Furthermore, there can be no assurance that the market price of our Common Stock immediately after a reverse split will be maintained for any period of time. Moreover, because some investors may view the reverse split negatively, there can be no assurance that the Reverse Split will not adversely impact the market price of our common stock or, alternatively, that the market price following the Reverse Split will either exceed or remain in excess of the current market price.

Effect of the Reverse Split, Fractional Shares

The number of shares of our Common Stock issued and outstanding would be reduced following the effective time of the Reverse Split in accordance with the following formula: for example, if our directors decide to implement a one for ten reverse split, every ten shares of our common stock owned by a stockholder will automatically be changed into and become one new share of our common stock, with ten being equal to the exchange ratio of the reverse split, as determined by the directors in their discretion. Stockholders should recognize that if a reverse split is effected, they will own a fewer number of shares than they presently own (a number equal to the number of shares owned immediately prior to the effective time divided by the exchange ratio, or such lesser exchange ratio as may be determined by our directors, subject to adjustment for fractional shares, as described below). The authorized number of shares of our common stock and the par value of our common stock under our Certificate of Incorporation would remain the same following the effective time of the reverse split.

Fractional shares which would otherwise be held by the stockholders of our common stock after the Reverse Split will be rounded up to the next whole share. We will issue one new share of our common stock for up to each 1,000 shares of our Common Stock held.

A Reverse Split of 1 to 1,000 may reduce the holdings any stockholder who currently holds less than 1,000 shares to no ownership in the Company. Rather than have such result, if the Company effectuates the Reverse Split, the Company will issue one new share of Common Stock to any of these stockholders. The intention of the Reverse Split is not to reduce the number of our stockholders. In fact, we do not expect that the Reverse Split will result in any material reduction in the number of our stockholders.

The number of stockholders of record would not be affected by the Reverse Split since we intend to issue one share of Common Stock to any stockholder whose shareholdings would be reduced to zero as a result of the Reverse Split.

We currently have no intention of going private, and this Reverse Split is not intended to be a first step in a going private transaction and will not have the effect of a going private transaction covered by Rule 13e-3 of the Exchange Act. Moreover, the Reverse Split does not increase the risk of us becoming a private company in the future.

The number of authorized but unissued shares of our Common Stock effectively will be increased significantly by the Reverse Split of our Common Stock. For example, based on the ­­­­­490,595,671 shares of our Common Stock outstanding on the Record Date, and the 750,000,000 shares of our Common Stock that are currently authorized under our certificate of incorporation, 259,404,329 shares of our Common Stock remain available for issuance presently. For example and purposes of illustration only, if we were to elect to implement a one for ten reverse split, the number of our outstanding shares of Common Stock would decrease from 490,595,671 shares to 49,059,567 shares, and 700,940,433 shares of Common Stock would remain available for issuance after the reverse split (assuming we do not increase the authorized number of shares). Therefore, such reverse split, if implemented, would have the effect of increasing the number of authorized but unissued shares of our common stock from 259,404,329 shares to 700,940,433 shares (the difference between 750,000,000 and the 49,059,567 which would be issued and outstanding).





We currently have an aggregate of 864,921,181 shares of common stock to be issued upon exercise of outstanding options and warrants, preferred shares and convertible notes. The issuance in the future of such additional authorized shares may have the effect of diluting the earnings per share and book value per share, as well as the stock ownership and voting rights, of the currently outstanding shares of our Common Stock.

Potential Anti-Takeover Effect

The effective increase in the number of authorized but unissued shares of our Common Stock may be construed as having an anti-takeover effect by permitting the issuance of shares to purchasers who might oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of our articles of incorporation or bylaws. Such a use of these additional authorized shares could render more difficult, or discourage, an attempt to acquire control of us through a transaction opposed by our board of directors. At this time, our Board does not have plans to issue any common shares resulting from the effective increase in our authorized but unissued shares generated by the Reverse Split.

No Appraisal Rights

Under the DGCL, stockholders are not entitled to appraisal rights with respect to the Reverse Split, and we will not independently provide stockholders with any such rights.

Accounting Matters

The Reverse Split will not affect the par value of our Common Stock. As a result, as of the effective time of the Reverse Split, the stated capital attributable to our Common Stock on our balance sheet will be reduced proportionately based on the Reverse Split ratio selected by our Board, and the additional paid-in capital account will be credited with the amount by which the stated capital is reduced. The per share net income or loss and net book value of our Common Stock will be restated because there will be fewer shares of Common Stock outstanding.

Federal Income Tax Consequences

We will not recognize any gain or loss as a result of the Reverse Split if it is effectuated by the Board.

The following description of the material federal income tax consequences of the reverse split to our stockholders is based on the Internal Revenue Code, applicable Treasury Regulations promulgated thereunder, judicial authority and current administrative rulings and practices in effect on the date of this Information Statement. Changes to the laws could alter the tax consequences described below, possibly with retroactive effect. We have not sought and will not seek an opinion of counsel or a ruling from the Internal Revenue Service regarding the federal income tax consequences of the Reverse Split. This discussion is for general information only and does not discuss the tax consequences that may apply to special classes of taxpayers (e.g., non-residents of the United States, broker/dealers or insurance companies). The state and local tax consequences of the Reverse Split may vary significantly as to each stockholder, depending upon the jurisdiction in which such stockholder resides. You are urged to consult your own tax advisors to determine the particular consequences to you.

In general, the federal income tax consequences of the Reverse Split will vary among stockholders depending upon whether they receive a reduced number of shares of our common stock in exchange for their old shares of our Common Stock. We believe that the likely federal income tax effects of the Reverse Split will be that a stockholder who receives solely a reduced number of shares of our Common Stock will not recognize gain or loss. With respect to a Reverse Split, such stockholder's basis in the reduced number of shares of our Common Stock will equal the stockholder's basis in his old shares of our Common Stock.

Our view regarding the tax consequences of a Reverse Split is not binding on the Internal Revenue Service or the courts. Accordingly, each stockholder should consult with his or her own tax advisor with respect to the potential tax consequences to him or her of the Reverse Split.

Procedure for Effecting the Reverse Split

If the Board decides to implement the Reverse Split at any time prior to September 21, 2016, we will promptly file a Certificate of Amendment with the Secretary of State of the State of Delaware to amend our existing Certificate of Incorporation. The Reverse Split will become effective on the date of filing the Certificate of Amendment, and on the effective date of such filing, each certificate representing pre-Reverse Split shares will be deemed for all corporate purposes to evidence ownership of post-Reverse Split shares. The Certificate of Amendment has received the unanimous approval of our Board and has also been approved by stockholders holding a majority of our outstanding shares of Common Stock. The text of the Certificate of Amendment is subject to modification to include such changes as may be required by the office of the Secretary of State of the State of Delaware and as the Board deems necessary and advisable to effect the Reverse Split, including the applicable ratio for the Reverse Split.





The Reverse Split will take place without any action on the part of the holders of our Common Stock and without regard to current certificates representing shares of our Common Stock being physically surrendered for certificates representing the number of shares of Common Stock each stockholder is entitled to receive as a result of the Reverse Split. New certificates for shares of our Common Stock will not be issued at this time. Stockholders who hold shares in certificated form should not do anything with their certificates at this time.

Upon a Reverse Split, we intend to treat stockholders holding our Common Stock in "street name", through a bank, broker or other nominee, in the same manner as registered stockholders whose shares are registered in their names. Banks, brokers or other nominees will be instructed to effect the Reverse Split for their beneficial holders holding our Common Stock in "street name". However, these banks, brokers or other nominees may have different procedures than registered stockholders for processing the Reverse Split. If you hold your shares with a bank, broker or other nominee and if you have any questions in this regard, we encourage you to contact your nominee.

INCREASE OF AUTHORIZED COMMON STOCK FROM 750,000,000 SHARES TO 3,000,000,000SHARES

The Company’s current Articles of Incorporation authorizes the issuance of 750,000,000 shares of Common Stock. As of the Record Date, there were 490,595,671 shares of Common Stock issued and outstanding. In addition, if all the outstanding options, warrants and preferred shares were exercised and/or converted for shares of Common Stock, there would be 1,355,516,852 shares of Common Stock issued (assuming that the Series C would convert on the basis of one to five). Since the Company is only authorized to issue 750,000,000, we need to increase our authorized share capital to account for all the current outstanding convertible securities.

Moreover, the purpose of the proposed increase in authorized share capital is to make available additional shares of Common Stock for issuance for general corporate purposes without the requirement of further action by the stockholders of the Company. In addition, the Company will need additional authorized shares in connection with establishing additional employee or director equity compensation plans or arrangements or for other general corporate purposes. There is currently no agreement or arrangement with respect to any of the foregoing other than as described above. Increasing the authorized number of shares of the Common Stock of the Company will provide the Company with greater flexibility and allow the issuance of additional shares of Common Stock in most cases without the expense or delay of seeking further approval from the stockholders.

The shares of Common Stock do not carry any pre-emptive rights. The adoption of the Amendment will not of itself cause any changes in the Company’s capital accounts.

The increase in authorized share capital will not have any immediate effect on the rights of existing holders of the Company’s Common Stock. However, the Board of Directors will have the authority to issue authorized shares of Common Stock without requiring future approval from the stockholders of such issuances, except as may be required by applicable law. To the extent that additional authorized shares of Common Stock are issued in the future, they will decrease the existing stockholders’ percentage equity ownership interests and, depending upon the price at which such shares of common stock are issued, could be dilutive to the existing stockholders. Any such issuance of additional shares of Common Stock could have the effect of diluting the earnings per share and book value per share of outstanding shares of Common Stock of the Company.

One of the effects of the increase in authorized share capital, if adopted, however, may be to enable the Board to render it more difficult to or discourage an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of present management. The Board would, unless prohibited by applicable law, have additional shares of Common Stock available to effect transactions (including private placements) in which the number of the Company’s outstanding shares would be increased and would thereby dilute the interest of any party attempting to gain control of the Company. Such action, however, could discourage an acquisition of the Company which the stockholders of the Company might view as desirable.





INCREASE OF CONVERSION RATE OF SERIES C PREFERRED FROM ONE TO FIVE SHARES OF COMMON STOCK

On February 18, 2014, we filed a Certificate of Designations of Preferences, Rights and Limitations of Series C Convertible Preferred Stock authorizing the issuance of up to 26,666,667 shares of Series C Convertible Preferred Stock. Concurrently, on February 18, 2014 we sold an aggregate of 33,333,332 shares of common stock, 26,666,667 shares of Series C and five year warrants to purchase up to an aggregate of 59,999,999 shares of common stock at an exercise price of $0.03 per share with gross proceeds to the Company of $1,799,999.99. Until the earlier of (i) February 18, 2017 or (ii) such time as none of these investors holds any Series C, said warrants, or shares of common stock underlying either the Series C or these warrants, in the event the Company issues or sells common stock or common stock equivalents at a per share price equal to less than $0.03 per share, as adjusted, each such investor shall be entitled to additional shares of Common Stock such that the aggregate purchase price paid by each such investor shall equal such lower price issuance, subject to certain customary exceptions.

Each share of Series C Convertible Preferred Stock is convertible, at the option of the holder at any time, into one share of common stock and has a stated value of $0.0001 per share. The conversion ratio of the Series C Convertible Preferred Stock is subject to adjustment in the case of stock splits, stock dividends, combination of shares and similar recapitalization transactions.

As a condition to the $250,000 financing the Company consummated in September 2015, the Company agreed to increase the conversion rate of the outstanding Series C from one share to five shares of common stock and to effectuate a reverse stock split prior to November 20, 2015. See the Current Report on Form 8-K filed by the Company on September 24, 2015. If the appropriate filings are not made by such time to take such actions, Alpha Capital Anstalt has the right to declare such failure an event of default pursuant to its secured convertible promissory note and to also require the Company to purchase its Series C.


Currently the holders of the outstanding Series C can convert the Series C to an aggregate of 26,666,667 shares of Common Stock. Upon the filing of the amendment to the Certificate of Designation of the Series C, the holders will have the right to convert their shares to an aggregate of 133,333,335 shares of Common Stock; however, one of the two holders of Series C has waived its right to receive the additional shares of Common Stock and has agreed to only receive 3,333,333 shares of Common Stock upon conversion even upon the amendment to the terms of the Series C. Accordingly, the holder of Series C will have the right to convert such shares for 83,333,335 shares of Common Stock after the amendment.

INCREASE OF AUTHORIZED SHARES OF SERIES D

On March 3, 2015, the Board of the Company designated and issued authorized 1,200,000 shares of the Company’s authorized Preferred Stock, par value $0.0001 per share, as Series D Convertible Preferred Stock. Each holder of the Series D shall have the number of votes on all matters submitted to the stockholders that is equal to the greater of one hundred votes for each one share of Series D and such number of votes per share of Series D that when added to the votes per shares of all other shares of Series D shall equal 50.1% of the outstanding voting record. The Series D are convertible into common stock in an amount equal to one share of the Company’s common stock for each one share of Series D. On March 9, 2015, the Company granted 1,000,000 shares of the Series D to each of three officers of the Company. Accordingly, the Company needs to increase the number of Series D authorized by the Certificate of Designation.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table lists, as of October 20, 2015, the number of shares of Common Stock beneficially owned by (i) each person or entity known to the Company to be the beneficial owner of more than 5% of the outstanding common stock; (ii) each officer and director of the Company, and (iii) all officers and directors as a group. Information relating to beneficial ownership of common stock by our principal stockholders and management is based upon information furnished by each person using “beneficial ownership” concepts under the rules of the Securities and Exchange Commission. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or direct the voting of the security, or investment power, which includes the power to vote or direct the voting of the security. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days. Under the Securities and Exchange Commission rules, more than one person may be deemed to be a beneficial owner of the same securities, and a person may be deemed to be a beneficial owner of securities as to which he or she may not have any pecuniary beneficial interest. Except as noted below, each person has sole voting and investment power.





Name of Beneficial Owner

Number Of Common Shares Beneficially Owned

Percentage Owned (1)

Number Of Series D Preferred Shares Beneficially Owned

Percentage Owned (5)

Percentage of Total Voting Power (6)

Saverio Pugliese (2)

32,672,887

6.7
%

1,000,000

33.33
%

27.04
%
David Wolfson (3)

6,839,556

1.4
%

1,000,000

33.33
%

21.78
%
Joseph Rienzi (4)

31,922,889

6.5
%

1,000,000

33.33
%

26.89
%

All directors and officers as a group (3 persons)

71,435,332

14.6
%

3,000,000

100
%

75.71
%

Sandor Capital

431,634,021
(10)
32.5
%

Alpha Capital Anstalt (7)

187,637,271
(11)
14.3
%

-

-

Brio Capital Master Fund LTD (8)

114,289,571
(12)
9.6
%

-

-

Barry Honig (9)

130,025,000
(13)
11.0
%

-

-

*Less than one percent


(1)
Based on 490,595,671 shares of our common stock issued and outstanding as of October 20, 2015.

(2)
Vice President and Director of the Company.

(3)
Chief Financial Officer and Director of the Company.

(4)
Interim President, Secretary and Director of the Company.

(5)
Based on 3,000,000 shares of Series D Preferred Stock outstanding.

(6)
Holders of our common stock are entitled to one vote per share. Holders of our Series D Preferred stock are entitled to the greater of one hundred votes for each share of Series D and such number of votes per share of Series D that when added to the votes per shares of all other shares of Series D shall equal 50.1% of the outstanding voting record.

(7)
Konrad Ackerman, as Director of Alpha Capital Anstalt has the voting and dispositive power over the securities held for the account of this beneficial owner.

(8)
Shaye Hirsch, as Director of Brio Capital Master Fund Ltd. has the voting and dispositive power over the securities held for the account of this beneficial owner.

(9)
Barry Honig has the voting and dispositive power over the securities held in his account.

(10)
Consists of 83,285,050 shares of common stock, 33,351,717,warrants to purchase shares of common stock and 11,663,921 shares of Convertible Preferred Series A Stock, 3,333,333 shares of Convertible Preferred Series C Stock, Convertible notes payable upon conversion to 133,333,333 Common shares, and ratchet shares of common stock of 166,666,667 pursuant to their notes.

(11)
Consists of 7,048,462 shares of common stock 3,922,142 warrants to purchase shares of common stock, 16,666,667 Convertible Preferred Series C Stock, and Convertible notes payable upon conversion to 97,500,000 Common shares, and Ratchet shares of common stock of 62,500,000 pursuant to their notes.

(12)
Consists of 29,289,571 shares of common stock, Convertible notes payable upon conversion to 43,333,333 Common shares, and Ratchet shares of common stock of 41,666,667 pursuant to their notes.

(13)
Consists of 25,000 shares of common stock. Convertible notes payable upon conversion to 46,666,667 Common shares, and Ratchet shares of common stock of 83,333,333 pursuant to their notes..






INTEREST OF CERTAIN PERSONS IN OR IN
OPPOSITION TO MATTERS TO BE ACTED UPON

Other than as described herein, no other person has any interest, direct or indirect, by security holdings or otherwise, in the matters herein which is not shared by all other stockholders.

WHERE YOU CAN FIND MORE INFORMATION

Additional information about us is contained in our periodic and current reports with the Securities and Exchange Commission (the "Commission"). These reports, their accompanying exhibits and other documents filed with the Commission, may be inspected without charge at the Public Reference Section of the Commission at Room 1024, 100 F Street, N.E. Washington, D.C. 20549. Copies of such materials may also be obtained from the Commission at prescribed rates. The Commission also maintains a Web site that contains reports, proxy and information statements and other information regarding public companies that file reports with the Commission. Copies of these reports may be obtained from the Commission's EDGAR archives at www.sec.gov/index.htm.


By Order of the Board of Directors,


/s/ Joseph Rienzi
President

October 20, 2015






EXHIBIT A



STATE OF DELAWARE

CERTIFICATE OF AMENDMENT
OF
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
BE ACTIVE HOLDINGS, INC.

Be Active Holdings, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware, DOES HEREBY CERTIFY THAT:

FIRST: That, by written consent of the Board of Directors of said corporation as of September 21, 2015, resolutions were duly adopted setting forth a proposed amendment to the Amended and Restated Certificate of Incorporation of said corporation, declaring said amendment to be advisable and in the best interest of the Corporation and its stockholders. The resolutions setting forth the proposed amendment are as follows:

WHEREAS, it is deemed to be advisable and in the best interest of the Corporation and its stockholders that the Corporation’s Amended and Restated Certificate of Incorporation be amended to increase the number of shares of common stock that the Corporation is authorized to issue from 750,000,000 to 3,000,000,000 shares.

NOW, THEREFORE, BE IT RESOLVED, that Article FIFTH of the Corporation's Amended and Restated Certificate of Incorporation be amended to read as follows:

“FIFTH: The total number of shares of stock which the Corporation shall have authority to issue is Three Billion One Hundred Fifty Million (3,150,000,000) which shall consist of (i) Three Billion (3,000,000,000) shares of common stock, par value $0.0001 per share (the "Common Stock"), and (ii) One Hundred Fifty Million (150,000,000) shares of preferred stock, par value $0.0001 per share (the "Preferred Stock").”

RESOLVED FURTHER, that the officers of the Corporation be, and each of them hereby is, authorized, empowered and directed, on behalf of the Corporation, to submit the foregoing amendments to the stockholders of the Corporation for consideration thereof; and

RESOLVED FURTHER, that following approval of the foregoing amendments by the stockholders of the Corporation, the officers of the Corporation be, and each of them hereby is, authorized, empowered and directed, on behalf of the Corporation, to prepare or cause to be prepared and to execute a Certificate of Amendment to the Corporation’s Amended and Restated Certificate of Incorporation, to file or cause to be filed said Certificate of Amendment with the Delaware Secretary of State, and to execute such other documents and take such other actions as such officer or officer shall deem necessary, appropriate or advisable in order to carry out the intent and purposes of the foregoing resolutions.

SECOND: That, thereafter, by written consent of the holders of the majority of the issued and outstanding shares of common stock of said corporation, the necessary number of shares required by statute were voted in favor of the amendment in accordance with the provisions of Section 228 of the General Corporation Law of the State of Delaware.

THIRD: That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment of Amended and Restated Certificate of Incorporation to be signed by its President this 21st day of September, 2015.



By: __________
Name: Joseph Rienzi

Title: President







STATE OF DELAWARE

CERTIFICATE OF AMENDMENT OF
CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS
OF
SERIES C CONVERTIBLE PREFERRED STOCK
OF
BE ACTIVE HOLDINGS, INC.


The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:

FIRST: The Board of Directors of Be Active Holdings, Inc. (the “Corporation”), on February 18, 2014, authorized the issuance of Series C Convertible Preferred Stock (the “Series C Stock”) by the filing of the Certificate of Designation thereof. On September 21, 2015, the Board of Directors and the majority of the holders of the Series C Stock adopted resolutions in lieu of a meeting pursuant to the General Corporation Law of the State of Delaware, setting forth the proposed amendment to the Certificate of Designation as follows:

Section 5(a) of the Certificate of Designation hereby deleted in its entirety and replaced with the following:

“(a) Conversion Right. Each holder of Series C Preferred Stock may, from time to time, convert any or all of such holder’s shares of Series C Preferred Stock into fully paid and non-assessable shares of Common Stock in an amount equal to five (5) shares of the Corporation’s common stock (the “Common Stock”) for each one (1) share of Series C Preferred surrendered.”

IN WITNESS WHEREOF, said corporation has caused this certificate to be signed this 8th day of September, 2015.





By: ________
Name: Joseph Rienzi
Title: President








STATE OF DELAWARE

CERTIFICATE OF AMENDMENT OF
CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS
OF
SERIES D CONVERTIBLE PREFERRED STOCK
OF
BE ACTIVE HOLDINGS, INC.

The corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify:

FIRST: The Board of Directors of Be Active Holdings, Inc. (the “Corporation”), on March 3, 2015, authorized the issuance of Series D Convertible Preferred Stock (the “Series D Stock”) by the filing of the Certificate of Designation thereof. On September 21, 2015, the Board of Directors and the majority of the holders of the Series D Stock adopted resolutions in lieu of a meeting pursuant to the General Corporation Law of the State of Delaware, setting forth the proposed amendment to the Certificate of Designation as follows:

Section 1 of the Certificate of Designation is hereby deleted in its entirety and replaced with the following:

“Section 1. Designation and Authorization. The Corporation shall be authorized to issue 3,000,000 shares of Series D Convertible Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”).”

IN WITNESS WHEREOF, said corporation has caused this certificate to be signed this 8th day of September, 2015.



By: ________
Name: Joseph Rienzi
Title: President